Prostate cancer affects 1 in 8 men*, presenting unique challenges in radiotherapy due to the mobility of the tumor. The ExacTrac Dynamic Implanted Marker Workflow for prostate cancer addresses this issue and is designed to enhance precision by correcting intrafractional movements. 🌐

Learn how this technology supports dose reduction with minimal impact on quality of life, addressing the growing need for ultra-hypofractionation in today’s treatments. Discover how precision in prostate cancer care begins here.

🔗 Visit our webpage to learn more: https://www.brainlab.com/radiosurgery-products/exactrac/implanted-marker-workflow/

#ProstateCancerTreatment #Radiotherapy #Brainlab #PrecisionMedicine

*Source: World Cancer Research Fund